Stericycle Inc (SRCL) Expected to Announce Quarterly Sales of $849.97 Million

Analysts forecast that Stericycle Inc (NASDAQ:SRCL) will post $849.97 million in sales for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have issued estimates for Stericycle’s earnings, with the highest sales estimate coming in at $866.30 million and the lowest estimate coming in at $834.50 million. Stericycle posted sales of $883.30 million during the same quarter last year, which suggests a negative year-over-year growth rate of 3.8%. The company is scheduled to announce its next earnings results on Thursday, August 1st.

According to Zacks, analysts expect that Stericycle will report full-year sales of $3.41 billion for the current financial year, with estimates ranging from $3.38 billion to $3.46 billion. For the next year, analysts expect that the firm will post sales of $3.50 billion, with estimates ranging from $3.45 billion to $3.58 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that follow Stericycle.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, February 28th. The business services provider reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.07. The business had revenue of $852.70 million for the quarter, compared to analyst estimates of $848.75 million. Stericycle had a positive return on equity of 12.56% and a negative net margin of 8.92%.

Several analysts recently weighed in on SRCL shares. BidaskClub raised Stericycle from a “strong sell” rating to a “sell” rating in a research note on Thursday, January 24th. Zacks Investment Research lowered Stericycle from a “hold” rating to a “sell” rating in a research note on Friday, February 15th. Goldman Sachs Group raised Stericycle from a “neutral” rating to a “buy” rating and set a $66.00 price objective on the stock in a research note on Friday, March 1st. BMO Capital Markets raised their price objective on Stericycle from $41.00 to $45.00 and gave the company a “market perform” rating in a research note on Monday, March 4th. Finally, ValuEngine raised Stericycle from a “strong sell” rating to a “sell” rating in a research note on Tuesday, March 5th. Four investment analysts have rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the stock. Stericycle has a consensus rating of “Hold” and a consensus target price of $59.00.

In other news, Director Mark C. Miller sold 260,314 shares of Stericycle stock in a transaction dated Tuesday, April 9th. The stock was sold at an average price of $57.18, for a total transaction of $14,884,754.52. Following the sale, the director now directly owns 325,848 shares of the company’s stock, valued at $18,631,988.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.30% of the company’s stock.

Hedge funds have recently made changes to their positions in the company. Vanguard Group Inc raised its position in shares of Stericycle by 2.6% during the third quarter. Vanguard Group Inc now owns 9,015,988 shares of the business services provider’s stock worth $529,058,000 after acquiring an additional 228,533 shares during the last quarter. BlackRock Inc. raised its position in shares of Stericycle by 40.9% during the fourth quarter. BlackRock Inc. now owns 7,616,828 shares of the business services provider’s stock worth $279,461,000 after acquiring an additional 2,210,880 shares during the last quarter. Clarkston Capital Partners LLC raised its position in shares of Stericycle by 2.7% during the first quarter. Clarkston Capital Partners LLC now owns 4,106,285 shares of the business services provider’s stock worth $223,464,000 after acquiring an additional 107,400 shares during the last quarter. Iridian Asset Management LLC CT bought a new position in shares of Stericycle during the first quarter worth about $168,624,000. Finally, Oregon Public Employees Retirement Fund raised its position in shares of Stericycle by 6,998.9% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 1,638,209 shares of the business services provider’s stock worth $45,000 after acquiring an additional 1,615,132 shares during the last quarter. 96.52% of the stock is currently owned by hedge funds and other institutional investors.

NASDAQ:SRCL opened at $48.79 on Thursday. The stock has a market capitalization of $4.45 billion, a P/E ratio of 10.96, a price-to-earnings-growth ratio of 1.90 and a beta of 1.11. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 1.17. Stericycle has a twelve month low of $34.36 and a twelve month high of $71.43.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.

Further Reading: Why is the ROA ratio important?

Get a free copy of the Zacks research report on Stericycle (SRCL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply